ID
22105
Description
The present pharmacokinetic study is designed to assess the pharmacokinetics of RSG XR as monotherapy in patients with mild Alzheimer's disease (AD) as such information will not be obtained from the current phase III trials . The study aims to enroll fourteen patients (seven of each APOE genotype). Each patient will receive a single oral dose of 4mg of RSG XR in the morning under fasted conditions and PK samples will be taken up to 36h. GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1
Lien
https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1
Mots-clés
Versions (2)
- 08/05/2017 08/05/2017 -
- 20/05/2017 20/05/2017 -
Téléchargé le
20 mai 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Follow-up Vital Signs ECG Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR) NCT00688207 / GSK-AVA109941
Follow-up Vital Signs ECG Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR) NCT00688207 / GSK-AVA109941
Description
12-Lead ECG
Alias
- UMLS CUI-1
- C0430456
Description
ECG Number
Type de données
text
Alias
- UMLS CUI [1,1]
- C1300638
- UMLS CUI [1,2]
- C0180600
Description
Start date of ECG
Type de données
date
Unités de mesure
- Day Month Year
Alias
- UMLS CUI [1,1]
- C0430456
- UMLS CUI [1,2]
- C0808070
Description
Planned Relative Time
Type de données
integer
Alias
- UMLS CUI [1]
- C0439564
Description
Start Time of ECG
Type de données
time
Unités de mesure
- Hr : Min
Alias
- UMLS CUI [1,1]
- C0430456
- UMLS CUI [1,2]
- C1301880
Description
Heart Rate
Type de données
float
Unités de mesure
- Beats/min
Alias
- UMLS CUI [1]
- C0018810
Description
PR Interval
Type de données
time
Unités de mesure
- msec
Alias
- UMLS CUI [1]
- C0429087
Description
QRS Duration
Type de données
time
Unités de mesure
- Hr : Min
Alias
- UMLS CUI [1]
- C0429025
Description
Uncorrected QT Interval
Type de données
time
Unités de mesure
- Hr : Min
Alias
- UMLS CUI [1]
- C1287082
Description
QTc interval
Type de données
time
Unités de mesure
- Hr : Min
Alias
- UMLS CUI [1]
- C0489625
Description
Enter Code for result from following list: 1=Normal 2=Abnormal - not clinically significant* 3=Abnormal - clinically significant 4=No result (not available) *Complete the Non-Serious Adverse Events (AE) or Serious Adverse Event (SAE) page(s) if clinically significant abnormalities meet the protocol definition for an AE or SAE. Complete the additional ECG Abnormalities page if clinically significant abnormalities are present.
Type de données
float
Alias
- UMLS CUI [1]
- C0438154
Similar models
Follow-up Vital Signs ECG Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR) NCT00688207 / GSK-AVA109941
C0011008 (UMLS CUI [1,2])
C2348792 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])